Funded by
the European Union
The answer goes beyond the pathogen itself. Disease emergence is shaped by the interaction between the infectious agent, the host and the environment, from biological
A new dedicated page on the EuCARE website explores findings from our Vaccine Hesitancy Study, an international multicentre study involving 2,079 healthcare workers across Lithuania,
On 1–2 October 2026, the EuCARE community will come together in Rome for the Pandemic Preparedness Rome Conference, two days dedicated to sharing knowledge, discussing
At this year’s EBM Live Conference in Oxford, Sara Gandini presented results from the EuCARE study on schools, bringing new evidence into the discussion on
How do SARS-COV-2 variants, coupled with other factors, influence the short- and long-term clinical course of COVID-19? Is the efficacy of vaccines or diagnostic tests affected as new variants emerge? Does treatment efficacy vary among variants? Do variants influence, and how, the spread in the school setting? Can we define a better testing and containment strategy in the school setting? What is the impact of containment measures, including schools closure, on pupils and teachers?
34 institutions from 4 continents collaborate to find answers to these and other crucial questions and to create a sustainable network to promptly tackle similar issues in the future.
FUNDED BY THE EC UNDER HORIZON-HLTH-2021-CORONA-01
- GRANT AGREEMENT NO 101046016
Get to know the project and its scope
Find out all the media news about the EuCARE Project.
